The Framingham facility alleges that labs who manipulate cannabis safety testing are enriching themselves at their expense.
The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.
Genzyme Corp. (Sanofi Genzyme) has disclosed sodium-dependent neutral amino acid transporter B(0)AT1 (SLC6A19) inhibitors reported to be useful for the treatment of phenylketonuria, among others.
The owner of six sandwich shop franchises located in different Central Massachusetts communities will be required to pay back ...